news
Petrovax Pharm will export Polyoxidonium® tablets to Slovakia
Petrovax Pharm will export Polyoxidonium® tablets to Slovakia. The company has received an updated EU Good Manufacturing Practice (GMP) certificate, which now covers the production of tablets in addition to lyophilized products. Issued in September 2026 following an inspection by Slovakia’s State Institute for Drug Control (SIDC), the certificate confirms that the company’s manufacturing operations and quality system comply with European requirements.
Reducing the years-long wait for innovative treatments: experts discussed solutions at BIOPROM-26
Petrovax Pharm presents new biotech medicines at BIOPROM-26
An original medicine for the targeted treatment of ovarian and HER2-negative breast cancer is authorized in Russia
A unified care pathway and immune status: experts discussed new approaches to pneumonia management
Russia’s Ministry of Health approves the country’s first domestically produced quadrivalent meningococcal vaccine
The risks of putting it off: experts discussed the link between prostatitis and men’s sexual and reproductive health
A look at the future of innovative therapy: Petrovax Pharm introduces young people to the modern biopharmaceutical industry
Russian Society of Urologists and Petrovax Pharm join forces to advance urological care in Russia
